Filing Flows › LifeMD (LFMD) › Q2 2026 › vs Q1 2026
LifeMD (LFMD) Q2 2026 vs Q1 2026 (quarter over quarter)
LifeMD's revenue fell $2.9M (-6%) from $50.2M in Q1 2026 to $47.3M in Q2 2026. The biggest changes: Telehealth −$1.8M (-9%); Telehealth Subscription Revenue −$1.1M (-4%).
LifeMD, Q2 2026: revenue $47.3M (-4% year over year), operating margin -15.1%, net loss $7.1M, operating cash flow −$6.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Telehealth Subscription Revenue | $29.3M | $30.4M | −$1.1M | -4% |
| Telehealth | $18.0M | $19.8M | −$1.8M | -9% |
| Revenue | $47.3M | $50.2M | −$2.9M | -6% |
| Net loss | $7.1M | $8.9M | −$1.8M | -20% |
| Costs & expenses | $54.4M | $59.1M | −$4.7M | -8% |
| Operating costs | $54.4M | $59.1M | −$4.7M | -8% |
| Cost of revenue | $5.3M | $5.9M | −$641K | -11% |
| Sales & marketing | $28.0M | $29.9M | −$1.8M | -6% |
| General & admin | $13.6M | $15.2M | −$1.5M | -10% |
| Other operating costs | $7.4M | $8.1M | −$671K | -8% |
| Operating cash sources | $8.0M | $1.3M | $6.7M | +507% |
| Depreciation & amortization | $325K | $321K | $4K | +1% |
| Share-based compensation | $790K | $1.4M | −$659K | -45% |
| Cash used in operations | $6.9M | −$445K | $7.4M | — |
| Net loss absorbed | $7.1M | $8.9M | −$1.8M | -20% |
| Working capital & other | $957K | −$7.5M | $8.5M | — |
Questions
How much did LifeMD's revenue grow quarter over quarter in Q2 2026?
LifeMD's revenue fell $2.9M (-6%) from $50.2M in Q1 2026 to $47.3M in Q2 2026.
What drove LifeMD's revenue change in Q2 2026?
Telehealth −$1.8M (-9%); Telehealth Subscription Revenue −$1.1M (-4%).